This, in turn, allows miR-133a to suppress the PAM signaling pathway in tumor cells by reducing the expression of EGFR and PIK3C2A targets (Fig. 3D), ultimately resulting in decreased growth and development of tumor cells. The gene discussed is PIK3C2A; the disease is neoplasm.